“…Subject Dose/Time Outcome [205,207] Heart Failure 1500 mg/day, 2 weeks Improved exercise capacity, reduced TC/HDL-c, and reduced hsCRP [208] Chronic Heart Failure 3000 mg/day, 30-45 days Decreased left ventricular end-diastolic volume with left ventricular dysfunction before revascularization [209] Chronic Heart Failure 3000 mg/day, 6 CBS, cystathionine β synthase deficiency; FBS, fasting blood sugar; HDL-c, high-density lipid cholesterol; hsCRP, high-sensitivity C-reactive protein; LDL-c, low-density lipid cholesterol; TC, total cholesterol.…”